Eli Lilly is developing a new experimental pill for weight loss.

The pill currently in mid-stage trials has reportedly revealed that at its highest dose people lose 15% of their body weight after 36 weeks.

Orforglipron was tested in 272 people with an average body weight of 240 pounds.

The study has found side effects of the drug to be common like nausea and vomiting.

While most side effects were mild, between 10-17% of participants stopped taking the drug because of them.